Book Description

SECTION 1: Airway Management -- Current Controversies 1. Can Sellick Maneuver Prevent Pulmonary Aspiration in the Critically Ill? 2. Etomidate vs. Ketamine -- What Should We Use for Intubation in ICU SECTION 2: Extracorporeal Therapies 3. Plasmapheresis: Current Indications in the Critically Ill 4. Are Super High-Flux Membrane Dialyzers the Future of RRT? 5. What is New in Artificial Liver Support Systems? SECTION 3: Sepsis 6. Back to the Genes: Does Genetic Polymorphism have a Role in Sepsis Management? 7. Controversies in Surviving Sepsis Guidelines 2021 8. Are We Back to Square One? Early Fluids vs. Vasopreressors in Septic Shock 9. Have We Achieved Balance in Fluid Therapy: Balanced Salt Solutions vs. Normal Saline? SECTION 4: Biomarkers 10. Novel Biomarkers During Circulatory Shock 11. Biomarkers in Acute Intoxications 12. Do Biomarkers have a Role in Patients with Primary Brain Injury? 13. Utility of MicroRNAs in the Critically Ill 14. Neutrophil to Lymphocyte Ratio in Critically Ill: A Simple but Useful Marker? 15. Do Vocal Biomarkers have a Future in Critical Care SECTION 5: COVID-19 Pandemic: Lessons Learnt 16. Awake Prone Positioning in ARDS? 17. Immunomodulators for COVID-19 Therapy 18. Has Critical Care Telemedicine Come of Age During the Pandemic 19. Post-COVID Conditions (PCCs) or Long COVID Syndrome 20. Capacity Building During Large Scale Disasters 21. Clearing the Air: Alternatives to Isolation Rooms SECTION 6: Mechanical Ventilation 22. Revisiting Exogenous Surfactant Therapy in Acute Lung Injury and ARDS 23. Mechanical Power 24. Volumetric Capnography in 2022 25. Metabolic Alkalosis in Critical Care: A Classical and Physicochemical Approach 26. Oxygen Revisited SECTION 7 28. High-flow Nasal Cannula: Beyond a COVID-19 Therapy 29. Cefiderocol 30. Newer Fluoroquinolones: Levonadifloxacin, Delafloxacin and Lascufloxacin 31. Newer Combinations of B-Lactam/B-Lactamase 32. Newer Tetracyclines -- Eravacycline and Omadacycline 33. Plazomicin: A New Aminoglycoside 34. Lefamulin: A Pleuromutilin Antibiotic 35. Pretomanid for Antitubercular Therapy 36. Contezolid Acefosamil: A New Oxazolidinone 37. Solithromycin and Nafithromycin: The New Macrolides 38. Benapenem and Sulopenem 39. The Dsb (Disulfide bond) 40. Antivirulence Strategies: The Future of Antibacterial Therapy 41. Alternatives to Conventional Antibacterials: Use of Nanomaterials 42. Newer Treatment Approach to Clostridioides Difficile - Fidaxomicin and Bezlotoxumab 43. Recent Advances for Immunotherapies Against Infectious Disease SECTION 8: What's New Elsewhere? 44. Risk Scoring Systems in Upper Gastrointestinal Bleed 45. Has Hypotension Prediction Index Come of Age 46. Postintensive Care Syndrome and Postintensive Care Syndrome-Family 47. Closed-Loop Hemodynamic Resuscitation In Shock 48. Is Electrical Impedance Tomography Finally Here to Stay 49. Cardiac Output Measurement: Capnodynamic Method and Auto VTI Tool 50. What's New in Glucose Management Technologies for the Critically-ill 51. Vitamins and Trace Element Supplementation for Critically Ill Patients in 2022 Index